Kera Capital Partners Inc. acquired a new position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 18,643 shares of the company’s stock, valued at approximately $393,000.
Several other large investors also recently made changes to their positions in AVTR. State Street Corp boosted its holdings in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after acquiring an additional 8,206,695 shares in the last quarter. Janus Henderson Group PLC grew its position in Avantor by 18.2% in the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock valued at $457,710,000 after purchasing an additional 2,719,615 shares during the period. Geode Capital Management LLC grew its position in Avantor by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock valued at $287,791,000 after purchasing an additional 739,667 shares during the period. 1832 Asset Management L.P. raised its holdings in Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after buying an additional 8,038,451 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its holdings in Avantor by 653.0% during the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock worth $159,740,000 after buying an additional 5,354,678 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Avantor Price Performance
AVTR opened at $22.14 on Friday. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The firm has a 50-day moving average of $21.45 and a 200 day moving average of $23.35. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The firm has a market cap of $15.07 billion, a P/E ratio of 48.13, a PEG ratio of 3.42 and a beta of 1.28.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Avantor
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- What is the Dogs of the Dow Strategy? Overview and Examples
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What Are Dividend Champions? How to Invest in the Champions
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Pros And Cons Of Monthly Dividend Stocks
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.